Welcome to our dedicated page for EXELON SEC filings (Ticker: EXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EXELON's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EXELON's regulatory disclosures and financial reporting.
Anna Richo, a director of Exelon Corp (EXC), received equity-based deferred compensation tied to Exelon common stock. On 09/30/2025 she was credited 950 deferred stock units at a reported price of $43.43, bringing her total indirect holdings in deferred stock units to 9,346 (that total includes 77 shares from dividend reinvestment). On the same date she was credited 694 phantom share equivalents694 underlying common shares$45.017,082 (including 55 accrued on the ex-dividend date). The transactions were reported on a Form 4 by an attorney-in-fact on behalf of the reporting person.
Insider acquisition and holding summary: Exelon director Linda P Jojo acquired 950 deferred stock units on 09/30/2025 at a reported price of $43.43 per unit under the Exelon Corp. Directors Deferred Stock Unit Plan. After the reported transaction, Ms. Jojo beneficially owns 53,270 shares (held indirectly). The filing notes that the balance includes 477 additional shares acquired through automatic dividend reinvestment. The Form 4 was submitted by David T. Skinner as attorney-in-fact and dated 10/01/2025.
David G. DeWalt, an Exelon Corp. director, reported an acquisition of 950 deferred stock units on 09/30/2025 at a reported price of $43.43 per unit. Following the transaction, Mr. DeWalt beneficially owned 2,145 units indirectly through the Exelon Corp. Directors Deferred Stock Unit Plan. The reported balance includes 11 additional shares acquired via automatic dividend reinvestment. The Form 4 was executed by David T. Skinner as attorney-in-fact and dated 10/01/2025.
Exelon Corp (EXC) director William P. Bowers reported transactions dated 09/30/2025. The filing shows he acquired 950 deferred stock units at $43.43 and acquired 1,805 phantom share equivalents in a non‑qualified deferred compensation plan valued at $45.01 per underlying share. He also disposed of 4,500 shares of common stock. Following these transactions he beneficially owned 17,838 shares indirectly (including 154 shares from dividend reinvestment) and directly held 17,097 phantom equivalents (including 133 credited on the ex‑dividend date). The phantom equivalents will be settled in cash upon termination of board service.
On 31 Jul 2025 Exelon Corporation (EXC) filed a Form 8-K under Items 2.02, 7.01 and 9.01. The company furnished—not filed—its second-quarter 2025 results via Exhibit 99.1 (press release) and Exhibit 99.2 (slide deck). A live earnings call is scheduled for 9:00 AM CT / 10:00 AM ET on the same day, with registration available through Exelon’s investor-relations site; a replay will be posted. No financial metrics, guidance figures or qualitative commentary appear in the body of the 8-K itself; investors must review the attached exhibits for detailed performance. Standard forward-looking-statement disclaimers are included, and the report is being furnished individually by Exelon and each of its utility subsidiaries (ComEd, PECO, BGE, Pepco Holdings, Potomac Electric Power, Delmarva Power & Light and Atlantic City Electric). Because the information is furnished, it will not be incorporated by reference into future SEC filings.
Form 4 insider activity – Exelon Corporation (EXC): On 06/30/2025 director Bryan K. Segedi acquired 954 deferred stock units of Exelon common stock at $43.25 each through the Exelon Corp. Directors Deferred Stock Unit Plan. The purchase increased his indirect holdings to 6,483 units, a figure that already includes 51 shares accumulated via dividend reinvestment. No shares were sold and no derivative positions were reported.
The transaction is valued at roughly $41k, immaterial to Exelon’s overall share count, but may signal incremental insider confidence. There are no indications of significant strategic shifts, option exercises, or complex hedging instruments in this filing.
Exelon Corp. (EXC) – Form 4 insider activity
Director Anna Richo reported two transactions dated 30-Jun-2025:
- 954 deferred stock units acquired at an implied price of $43.25 under the Directors Deferred Stock Unit Plan, raising her indirect holding in that plan to 8,320 units.
- 719 deferred phantom share equivalents credited at an implied value of $43.42 within a non-qualified deferred-compensation account, increasing the direct balance of phantom units to 6,334.
The filing also notes routine accruals from dividend reinvestment (68 common shares) and phantom units (50 equivalents). All instruments will ultimately settle in cash or shares upon the director’s board service termination. No dispositions were reported.
The aggregate value of the reported acquisitions is modest relative to Exelon’s market capitalization, but insider accumulation may be viewed as a minor vote of confidence.
On 06/30/2025, Exelon Corporation (EXC) director Charisse R. Lillie filed a Form 4 disclosing the acquisition of 954 deferred stock units (DSUs) at an implied price of $43.25 each through the company’s Directors Deferred Stock Unit Plan. Her indirect DSU balance increased to 9,505 units. The filing also shows 7,246 shares of common stock held directly and 3,752 phantom share equivalents in a non-qualified deferred compensation plan. The transaction represents routine board compensation rather than an open-market purchase and is unlikely to have a material impact on Exelon’s share count or market perception.